Crossmark

Sustained efficacy of collars containing 10% w/w imidacloprid and 4.5% w/w flumethrin (Seresto®) in dogs against laboratory challenge with Haemaphysalis longicornis (Neumann, 1901) ticks

Crossref DOI link: https://doi.org/10.1186/s13071-022-05206-w

Published Online: 2022-03-05

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Meyer, Leon

Lekouch, Nouha

Altreuther, Gertraut https://orcid.org/0000-0001-6985-5582
Schunack, Bettina

Pollmeier, Matthias
License Information

Text and Data Mining valid from 2022-03-05

Version of Record valid from 2022-03-05
More Information

Article History

Received: 21 December 2021

Accepted: 15 February 2022

First Online: 5 March 2022

Declarations

:

: Animals were managed similarly and in compliance with the relevant Animal Care and Use Committee approvals.

: Not applicable.

: This study was funded by Bayer Animal Health GmbH, now an Elanco Animal Health company. BS, GA and MP are employees of Bayer Animal Health. LM and NL were the contracted study investigator and assistant investigator, respectively.

Document is current

Any future updates will be listed below